R J Bio-Tech Ltd Financials
Company Logo

R J Bio-Tech Ltd Financial Statement

R J Bio-Tech Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

Particulars
Mar 2018
Revenue1.82
Operating Expense17.07
Net Profit-17.41
Net Profit Margin-956.59
Earning Per Share-36.88
EBIDTA-15.25
Effective Tax RateTBA
Invest in R J Bio-Tech Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions

R J Bio-Tech Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2022
Total Revenue Annual13.90
Operating Expenses Annual12.59
Operating Profit Annual1.83
Interest Annual5.82
Depreciation0.07
Net Profit Annual-4.05
Tax AnnualTBA

R J Bio-Tech Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2022
Cash Flow at the Beginning0.05
Cash Flow from Operations-4.72
Cash Flow from InvestingTBA
Cash Flow from Financing4.68
Cash Flow at the End0.01

R J Bio-Tech Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2022
PBDIT Margin (%)13.24
PBIT Margin (%)12.73
PBT Margin (%)10.57
Net PROFIT Margin (%)-29.14
Return On Networth / Equity (%)TBA
Return On Networth /Employed (%)TBA
Return On Assets (%)-566.42
Total Debt / Equity (X)TBA
Asset Turnover Ratio (%)19.44

R J Bio-Tech Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars
Mar 2022
Fixed Assets Annual1.53
Total Current Assets Annual0.29
Non Current Assets Annual1.63
Total Shareholders Funds Annual-50.34
Total Assets Annual1.92

R J Bio-Tech Ltd Earning Calls

No Data Availabe

Get Your FAQs Right

As of Nov 14, 2024, R J Bio-Tech Ltd has a market capitalization of 3.23 Cr. Value Research classifies it as a Micro-Cap company.
Yes, R J Bio-Tech Ltd is debt-free with a debt-to-equity ratio of -1.01.
In FY 2023 , R J Bio-Tech Ltd recorded a total revenue of approximately 0 Cr marking a significant milestone in the company's financial performance.
R J Bio-Tech Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising approximately -0.2% and -100.0% annually, respectively..
R J Bio-Tech Ltd's current PE ratio is -323.00.
R J Bio-Tech Ltd's ROCE averaged -104.1% from the FY ending March 2022 to 2024, with a median of -69.8%. It peaked at -1.1% in March 2024, reflecting strong capital efficiency over the period..
R J Bio-Tech Ltd's latest EBIT is Rs. -0.01 Cr, surpassing the average EBIT of Rs. -1.20 Cr over the 5 years..